Predictors of Potentially Unnecessary Transfers to Pediatric Emergency Departments

Kathleen R Richard1,2, Kyle L Glisson3, Nipam Shah4

  • 1Department of Pediatrics.

Hospital Pediatrics
|April 24, 2020
PubMed

Insights

A study found that 87.7% of pediatric emergency department (ED) transfers may be unnecessary, highlighting disparities in these transfers. Further research is needed to reduce these potentially avoidable patient transports and healthcare costs.

Area of Science:

  • Pediatric Healthcare Research
  • Health Services Research
  • Emergency Medicine

Background:

  • Rising US healthcare expenditures necessitate cost-reduction strategies.
  • Pediatric emergency department (ED) transfers represent a significant area for potential cost savings.
  • Understanding the burden and factors influencing potentially unnecessary pediatric ED transfers is crucial.

Purpose of the Study:

  • To quantify the proportion of potentially unnecessary pediatric emergency department (ED) to ED transfers.
  • To identify demographic and clinical factors associated with these transfers.

Main Methods:

  • Retrospective analysis of Pediatric Hospital Information Systems data from January 1, 2013, to December 31, 2014.
  • Inclusion of patients aged 19 years and younger transferred to participating hospital EDs.
  • Definition of necessary transfers based on disposition (death, admission >24 hours) or specific interventions (sedation, advanced imaging, OR, critical care charges).

Main Results:

  • Out of 1,698,882 analyzed encounters, 87.7% were classified as potentially unnecessary transfers.
  • Factors positively associated with unnecessary transfers included ages 1-4 years, female sex, African American race, urban residence, and weekend transfers.
  • Factors negatively associated with unnecessary transfers included non-Hispanic ethnicity, minor severity, and commercial insurance.

Conclusions:

  • Significant disparities exist in pediatric ED-to-ED transfers, with a high proportion deemed potentially unnecessary.
  • Further investigation into the causes of these disparities is warranted.
  • Research should focus on strategies to mitigate unnecessary transfers, reduce resource consumption, and lessen patient and family burdens.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
194
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
149
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
177
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
174
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
133
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.7K